Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
The debate between points and cash back is ongoing. Understand the benefits of each to determine which suits you best.
28,655 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Bitcoin steadies as US-Iran tensions ripple through oil and inflation bets. Analysts say these forces could push BTC ...
Andy Burnham has surged to the top as Labour's prime ministerial favorite, triggering cryptocurrency industry hopes f...
Ethereum slid to multi-month lows as crypto markets flash renewed risk-off signals. Analysts warn that the sell-off c...
As mortgage costs stay elevated, Opendoor racked up another quarterly loss. Forget opendoor technologies: this turns ...
The latest CBO outlook warns the debt path is moving into uncharted territory by 2035. The report shows national debt...
Anthropic confirms a high-profile hire from Tesla's AI team, expanding its competitive edge in the AI race. The move ...
A DeFi lending protocol disclosed a $403,000 exploit against tokenized stocks used as collateral, exposing weaknesses...
As Ford grows its electric lineup, investors weigh profitability, supply chains, and policy risk. The debate over for...
As the Iran conflict returns energy markets to sharper swings, officials closely monitor iran for signs inflation cou...
The Strategic Petroleum Reserve sits near a 40-year low, yet Wall Street focuses on production and demand signals rat...
With inflation stubborn and growth resilient, traders are debating whether the Fed will hold rates in June or pivot l...